StockData
Oncotelic Therapeutics, Inc. logo

Oncotelic Therapeutics, Inc. (OTLC) bonds

OTLCOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.02+0.00 (+11.45%)

Close on Oct 19, 2026Market cap $8.66MP/E 0.0Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Oncotelic Therapeutics reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in Oncotelic Therapeutics's 10-Q for the period ended Jun 30, 2026

IssueCouponCarrying value
August Twenty Twenty One Convertible Notes
Convertible
–$869.79K
Convertible Debentures
Convertible
–$164.44K
Fall Two Thousand Nineteen Notes
Convertible
–$141.46K
GMP Note2.00%–
GMP Note Two2.00%–
JH Darbie PPM Two Debt
Convertible
–$19.11K
JH Darbie PPM3 Debt
Convertible
–$1.85M
January Two Thousand Twenty Six Note
Convertible
–$314.15K
July Two Thousand Twenty Five Note
Convertible
–$595.18K
July Two Thousand Twenty Two Note
Convertible
–$465.26K
March Twenty Twenty Two Notes
Convertible
–$61.48K
May And June Two Thousand Twenty Two Note
Convertible
–$809.49K
May Two Thousand Twenty Two Note–$19.11K
Pacific Pier Two Thousand Twenty Six Note
Convertible
–$129.45K
Unsecured Convertible Note Purchase Agreements
Convertible
2.00%–

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?